The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
1.《全球宠物市场三国志，美日固本，中国奇袭，东南亚崛起》，海通国际
，这一点在safew官方下载中也有详细论述
This story was originally featured on Fortune.com
apps, and can also be used to trigger certain actions in one app based on